| 2024-10-29 |
SULPTHN009114NYC |
RISING PHARMA HOLDINGS INC |
6233.0 kg |
300490
|
662 CARTONS ON 35 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION CARBAMAZEPINE EXTENDED RELEASE TABLETS 400MG, HS CODE NO.: 3004 90 99 NET WT: 4569.860 KGS |
| 2024-10-29 |
SULPTHN009115NYC |
RISING PHARMA HOLDINGS INC |
6954.0 kg |
300490
|
994 CARTONS ON 33 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, USP 75MG 60CT HS CODE NO.: 3004 90 69 NET WT: 4768.800 KGS |
| 2024-10-25 |
ONEYPNQE07310A01 |
SST CORP |
2516.0 kg |
300510
|
PHARMACEUTICAL |
| 2024-10-24 |
SULPTHN009060NYC |
RISING PHARMA HOLDINGS INC |
7500.0 kg |
300490
|
1418 CARTONS ON 40 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION HS CODE NO.:3004 90 69 NET WT: 5366.180 KGS |
| 2024-10-15 |
CMDUAMC2290293 |
RISING PHARMA HOLDINGS INC |
5568.0 kg |
300490
|
------------ TEMU9882728 DESCRIPTION---------30049099 (HS) 1 X 40FT HC RF CONTAINER CONTAINS TOTAL 29 PACKAGES 812 CARTONS ON 29 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 204969 (4500014144) 205000 (4500014327) 205022 (4500014506) 204931 (4500013597) 205055 (4500014881) 205061 (4500014888) 205062 (4500014889) 205067 (4500015018) OXYBUTYNIN CHLORIDE EXTENDED -RELEASE TABLETS, USP 15MG 100CT NDC 64980-211-01 - HTS 3004.90.9190 HS CODE NO.: 3004 90 99 PENTOXIFYLLINE TAB ER 400MG, 500 CT NDC 16571-856-50- HTS 3004.90.9291 HS CODE NO.: 3004 90 99 CARBAMAZEPINE EXTENDED RELEASE TABLETS 100MG,100 CT NDC 16571-680-01-HTS CODE 3004.90.9230 HS CODE NO.: 3004 90 81 CARBAMAZEPINE EXTENDED RELEASE TABLETS 200MG,100CT NDC 16571-681-01-HTS CODE 3004.90.9230 HS CODE NO.: 3004 90 81 MECLIZINE HYDROCHLORIDE CHEWABLE TABLETS 25MG 100CT NDC 16571-824-01-HTS 3004.90.9280 HS CODE : 3004 90 39 MECLIZINE HYDROCHLORIDE CHEWABLE TABLETS 25MG 1000 CT NDC 16571-824-10 - HTS 3004.90.9280 HS CODE : 3004 90 39 OXYBUTYNIN CHLORIDE EXTENDED -RELEASE TABLETS, USP 10MG 500CT NDC 64980-210-05 - HTS 3004.90.9190 HS CODE NO.: 3004 90 99 CIPROFLOXACIN TABLETS, USP 500MG 100CT NDC 16571-412-10 - HTS 3004.20.006 HS CODE NO.: 3004 20 13 CUSTOMS INVOICE NO.: 1240626074 DT.31.08.2024 1240626075 DT.31.08.2024 1240626115 DT.31.08.2024 COMMERCIAL INVOICE NO.: 90029394 DT.31.08.2024 90029395 DT.31.08.2024 SB NO: 3664655 DT.01.09.2024 3664646 DT.01.09.2024 3664659 DT.01.09.2024 NET WT : 4,259.020 KGS FREIGHT COLLECT TOTAL PKGS 29 PK -------------GENERIC DESCRIPTION-------------CARGO IS STOWED IN A REFRIGERATED CONTAINER SAT THE SHIPPER S REQUESTED CARRYING TEMPERATUOF 18 DEGREES CELSIUS CMA-CGM NVOCC HOUSE BILLS CROSS REFERECNE WITMASTER BILLS NO.AMC2281665 |
| 2024-10-15 |
CMDUAMC2290334 |
RISING PHARMA HOLDINGS INC |
7948.0 kg |
300490
|
------------ CGMU5380499 DESCRIPTION---------1 X 40FT HC RF CONTAINER CONTAINS TOTAL 36 PACKAGES 705 CARTONS ON 36 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATIPER ORDER NO.: 205034 (4500014680) 205059 (4500014886) 205018 (4500014502) 205066 (4500015011) GLIPIZIDE EXTENDED-RELEASE TABLETS 2.5MG 30CTNDC 64980-279-03 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, US75MG 500CT NDC 16571-201-50 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 CUSTOMS INVOICE NO.: 1240626086 DT.31.08.2024 1240626105 DT.31.08.2024 COMMERCIAL INVOICE NO.: 90029382 DT.31.08.2024 SB NO: 3654217 DT.31.08.2024 3661923 DT.31.08.2024 NET WEIGHT : 6,138.000 KGS FREIGHT COLLECT -------------GENERIC DESCRIPTION-------------CARGO IS STOWED IN A REFRIGERATED CONTAINER STHE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS CMA-CGM NVOCC HOUSE BILLS CROSS REFERECNE WITMASTER BILLS NO.AMC2285990 |
| 2024-10-12 |
CMDUAMC2283169 |
RISING PHARMA HOLDINGS INC |
6556.0 kg |
300490
|
------------ AMCU9346390 DESCRIPTION---------1 X 40FT HC RF CONTAINER CONTAINS TOTAL 37 PACKAGES 754 CARTONS ON 37 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATIPER ORDER NO.: 205062 (4500014889) 205067 (4500015018) OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS,10MG 100CT NDC 64980-210-01 - HTS 3004.90.9190 HS CODE NO.: 3004 90 99 OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS,10MG 500CT NDC 64980-210-05 - HTS 3004.90.9190 HS CODE NO.: 3004 90 99 CIPROFLOXACIN TABLETS, USP 250MG 100CT NDC 16571-411-10 - HTS 3004.20.0060 HS CODE NO.: 3004 20 13 NET WEIGHT : 4,636.010 KGS FREIGHT PREPAID CMA-CGM NVOCC HOUSE BILLS CROSS REFERECNE WI MASTER BILLS NO. AMC2274825 -------------GENERIC DESCRIPTION-------------CARGO IS STOWED IN A REFRIGERATED CONTAINER STHE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS |
| 2024-10-12 |
CMDUAMC2287134 |
RISING PHARMA HOLDINGS INC |
8930.0 kg |
300490
|
------------ TEMU9904745 DESCRIPTION---------1 X 40FT HC RF CONTAINER CONTAINS TOTAL 39 PACKAGES 1139 CARTONS ON 39 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATIPER ORDER NO.: 205059 (4500014886) 205066 (4500015011) 205057 (4500014883) 205067 (4500015018) GLIPIZIDE EXTENDED-RELEASE TABLETS 10MG 500CTNDC 64980-281-05 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, US75MG 500CT NDC 16571-201-50 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 CIPROFLOXACIN TABLETS, USP 500MG 100CT NDC 16571-412-10 - HTS 3004.20.0060 HS CODE NO.: 3004 20 13 CUSTOMS INVOICE NO.: 1240625891 DT.31.07.2024 1240626021 DT.27.08.2024 1240626022 DT.27.08.2024 COMMERCIAL INVOICE NO.: 90029322 DT.27.08.202SB NO: 2909557 DT.02.08.2024 NET WT : 8,930.070 KGS FREIGHT COLLECT -------------GENERIC DESCRIPTION-------------CARGO IS STOWED IN A REFRIGERATED CONTAINER STHE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS CMA-CGM NVOCC HOUSE BILLS CROSS REFERECNE WITMASTER BILLS NO.AMC2281660 |
| 2024-10-05 |
MEDUJC153387 |
RISING PHARMA HOLDINGS INC |
7782.0 kg |
300490
|
1 X 40FT HC RF CONTAINER C ONTAINS 1047 CAR TONS ON 38 PACKAGES TOTAL ONE TH OUSAND & F ORTY SEVEN CARTO N ON THIRTY EIGHTY PACKAGE SSHIPMENT OF PHARMACEUT ICAL FINISHED FORMU LATION AS PER ORDER NO.: 205000 (4500014327 ) 205039 (45 00014686) 205066 (450001 501 1) OXYBUTYNIN CHLORID E EXTENDED-RELEASE TA BLETS , USP 15MG 100CT NDC 649 80-211-01 - HTS 3004.90.91 90 HS CODE NO.: 3004 90 99 DICLOFENAC SODIUM DEL AYED-RELEASE TABLETS, USP 50MG 100CT NDC 16571-202 -10 - HTS 3004 .90.9120 H S CODE NO.: 3004 90 69 C USTOM S INVOICE NO.: 1240 625836 DT.31.07.2024 124 0625850 DT.31.07.2024 CO MMERCIAL INVOI CE NO.: 90 029189 DT.31.07.2024 900 29190 DT.31.07.2024 SB N O: 2864105 DT.31.07. 202 4 2864103 DT.31.07.2024 NET WT : 5,624 .610 KG S FREIGHT PREPAID THE TE MPERATUR E TO BE SET AT +18 DEGREE CELCIUS IN ACCORDA NCE WITH SHIPPER INSTRUCTI ONS |
| 2024-10-05 |
MEDUJC153502 |
RISING PHARMA HOLDINGS INC |
8521.0 kg |
300490
|
1 X 40FT HC RF CONTAINER C ONTAINS 1073 CAR TONS ON 42 PACKAGES TOTAL ONE TH OUSAND AND SEVENTY THREE C ARTON ON FORTY TWO PACKAGE S SHIPMENT OF PHARMACEUT ICAL FINISHED FORMU LATION AS PER ORDER NO.: 205066 (4500015011 ) 205022 (45 00014506) 205018 (450001 450 2) 205034 (4500014680 ) 205039 (450001468 6) DICLOFENAC SODIUM DELAYED- RELEASE TABLETS, USP 50MG 100CT NDC 16571-202-10 - HTS 300 4.90.9120 HS COD E NO.: 3004 90 69 OXYBUT YNIN CHLORIDE EXTENDED-REL EASE TABLETS, USP 10MG 100 CT NDC 64980-210-01 - HT S 3004.9 0.9190 HS CODE N O.: 3004 90 99 OXYBUTYNI N CHLORIDE EXTENDED-RELEAS E TABLETS, USP 15 MG 100CT NDC 64980-211-01 - HTS 3 004.90.9190 HS CODE NO.: 3004 90 99 GLIPIZIDE EX TEN DED-RELEASE TABLETS 5MG 500CT NDC 64980-280 -05 - HTS CODE 3004.90.9190 HS CODE NO.: 300490 99 GLIPIZIDE EXTENDED-RELEASE TABLETS 5MG 100CT NDC 6 4980-280-01 - HTS CODE 300 4.9 0.9190 HS CODE NO.: 3 004 90 99 CUSTOMS I NVOIC E NO.: 1240625837 DT.31. 07.2024 12 40625889 DT.31 .07.2024 1240625893 DT.3 1.0 7.2024 COMMERCIAL INV OICE NO.: 90029225 DT.31 .07.2024 90029226 DT.31. 07.2024 SB NO: 2877436 DT.01.08.2024 2877838 D T.01 .08.2024 2877876 DT. 01.08.2024 NET WT : 6,07 9.600 KGS FREIGHT PREPA ID THE TEM PERATURE TO B E SET AT +18 DEGREE CELCIU S INACCORDANCE WITH SHIPP ER INSTRUCTIONS |
| 2024-10-05 |
MEDUJC153452 |
RISING PHARMA HOLDINGS INC |
9689.0 kg |
300490
|
1080 CARTONS ON 42 PACKAGE S ONE THOUSAND A ND EIGHT Y CARTON ON FORTY TWO PACK AGES SH IPMENT OF PHARMAC EUTICAL FINISHED FORMULATI ON AS PER ORDER NO.: 205 064 (4500014891) 205066 (4500015011) DICLOFENAC SODIUM DELA YED-RELEASE TAB LETS, USP 75MG 60CT NDC 165 71-201-06 - HTS 3004.90 .9120 HS CODE NO.: 3004 90 69 DICLOFENAC SODIUM DELAYED-RELEAS E TABLETS, U SP 75MG 500CT NDC 16571- 201-5 0 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 CUSTOMS INVOICE NO.: 12 40625855 DT.31.07.20 24 C OMMERCIAL INVOICE NO.: 90 029193 DT. 31.07.2024 SB NO: 2864288 DT.31.07.2024 NET WT : 7,430.000 KGS FREIGHT PREPAID THE TEMP ERATURE TO BE SET AT +18 D EGREE CELCIUS IN A CCORDANC E WITH SHIPPER INSTRUCTION S |
| 2024-10-05 |
MEDUJC153650 |
RISING PHARMA HOLDINGS INC |
7928.0 kg |
300490
|
1 X 40FT HC RF CONTAINER C ONTAINS 1167 CAR TONS ON 40 PACKAGES ONE THUSOAND ONE HUNDRE D SIXTY SEVEN C ARTON ONFORTY PACKAGES. SHIP MENT OF PHARMACEUTICA L FINISHED FORMULATION AS PER ORDER NO.: 205063 (4 500014890) 20 5055 (45000 14881) 205067 (450001501 8) T OLTERODINE TARTRATE TAB 2 MG 60 CT NDC 1657 1 -127-06- HTS 3004.90.9265 HS CODE NO.: 300490 99 CARBAMAZEPINE EXTENDED R ELEASE TABLET S 100MG,100 C T NDC 16571-680-01-HTS C ODE 3004.90.9230 HS CODE NO.: 3004 90 81 CIPR OFL OXACIN TABLETS, UPS 500MG 100CT NDC 165 71-412-10 - HTS 3004.20.0060 HS COD E NO.: 3004 20 13 CUSTOM S INVOICE NO.: 12406258 3 3 DT.31.07.2024 12406258 34 DT.31.07.2024 COMMERC IAL INVOICE NO.: 90029188 DT.31.0 7.2024 SB NO: 2854477 DT.31.07.2024 28 58 301 DT.31.07.2024 NET WT : 6,118.340 KGS T HE TEMPERATURE TO BE SET A T +18 DEGREE CELCIUS IN AC CORDANCE WITH SHIPPER INST RUC TIONS |
| 2024-09-21 |
CMDUAMC2277551 |
RISING PHARMA HOLDINGS INC |
7355.0 kg |
300420
|
------------ CGMU5598768 DESCRIPTION---------1 X 40FT HC RF CONTAINER CONTAINS TOTAL 40 PACKAGES 1125 CARTONS ON 40 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATIPER ORDER NO.: 205057 (4500014883) 205059 (4500014886) 205060 (4500014887) 205064 (4500014891) CIPROFLOXACIN TABLETS, UPS 500MG 500CT NDC 16571-412-50 - HTS 3004.20.0060 HS CODE NO.: 3004 20 13 GLIPIZIDE EXTENDED-RELEASE TABLETS 5MG 500CT NDC 64980-280-05 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 LORATADINE TABLETS USP 10 MG 100CT NDC 16571-0822-01 - HTS CODE 3004.90.9280 HS CODE NO.: 3004 90 39 DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, US50MG 60CT NDC 16571-202-06 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 CUSTOMS INVOICE NO.: 1240625835 DT.31.07.2024 1240625888 DT.31.07.2024 COMMERCIAL INVOICE NO.: 90029223 DT.31.07.202SB NO: 2887270 DT.01.08.2024 2887245 DT.01.08.2024 NET WEIGHT : 5,172.870 KGS FREIGHT COLLECT CMA-CGM NVOCC HOUSE BILLS CROSS REFERECNE WITMASTER BILLS NO :AMC2268055 -------------GENERIC DESCRIPTION-------------CARGO IS STOWED IN A REFRIGERATED CONTAINER STHE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS |
| 2024-09-21 |
CMDUAMC2277544 |
RISING PHARMA HOLDINGS INC |
7022.0 kg |
300490
|
------------ CGMU5556248 DESCRIPTION---------1 X 40FT HC RF CONTAINER CONTAINS TOTAL 41 PACKAGES 979 CARTONS ON 41 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATIPER ORDER NO.: 205054 (4500014880) 205056 (4500014882) 205059 (4500014886) ATENOLOL TABLETS, USP 100MG 1,000CT NDC 64980-439-10 - HTS 3004.90.9120 HS CODE NO.: 3004 90 74 CETIRIZINE HYDROCHLORIDE TABLETS 5MG 100CT NDC 16571-401-10 - HTS 3004.90.9180 HS CODE NO.: 3004 90 31 GLIPIZIDE EXTENDED-RELEASE TABLETS 2.5MG 30CTNDC 64980-279-03 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 CUSTOMS INVOICE NO.: 1240625808 DT.30.07.2024 1240625820 DT.30.07.2024 COMMERCIAL INVOICE NO.: 90029184 DT.30.07.202SB NO: 2811422 DT.30.07.2024 2826252 DT.30.07.2024 NET WEIGHT : 4,955.460 KGS FREIGHT PREPAID CMA-CGM NVOCC HOUSE BILLS CROSS REFERECNE WITMASTER BILLS NO :AMC2268051 -------------GENERIC DESCRIPTION-------------CARGO IS STOWED IN A REFRIGERATED CONTAINER S THE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS |
| 2024-09-14 |
SULPTHN008814NYC |
RISING PHARMA HOLDINGS INC |
8773.0 kg |
300490
|
863 CARTONS ON 40 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION HS CODE : 30049069 NET WT: 6943.070 KGS TEMPERATURE TO BE SET AT 18.0 C |
| 2024-09-14 |
SULPTHN008815NYC |
RISING PHARMA HOLDINGS INC |
7765.0 kg |
300490
|
1072 CARTONS ON 38 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 205064 4500014891 205063 4500014890 205059 4500014886 HS CODE : 30049069 NET WT: 5647.760 KGS TEMPERATURE TO BE SET AT 18.0 C |
| 2024-09-14 |
SULPTHN008816NYC |
RISING PHARMA HOLDINGS INC |
6983.0 kg |
300490
|
940 CARTONS ON 35 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 205066 4500015011 205024 4500014523 2050484500014728 HS CODE : 30049069, 30049081 NET WT: 5076.560 KGS TEMPERATURE TO BE SET AT 18.0 C |
| 2024-09-13 |
SULPTHN008768NYC |
RISING PHARMA HOLDINGS INC |
9972.0 kg |
300490
|
814 CARTONS ON 40 PACKAGES SHIPMENT OF PHARMACEUTICAL PHARMACEUTICAL FINISHED HS CODE : 3004 90 69 |
| 2024-08-29 |
CMDUAMC2267478 |
RISING PHARMA HOLDINGS INC |
4818.0 kg |
300490
|
------------ TEMU9577196 DESCRIPTION---------1 X 40FT HC RF CONTAINER CONTAINS TOTAL 24 PACKAGES 540 CARTONS ON 24 PACKAGES (FIVE HUNDRED FORTY CARTONS ON TWENTY FOUR PACKAGES ONLY) SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATI PER ORDER NO.: 204969 (4500014144) 205022 (4500014506) 205039 (4500014686) 205048 (4500014728) OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS,15MG 100CT NDC 64980-211-01 - HTS 3004.90.9190 HS CODE NO.: 3004 90 99 OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS,5MG 100CT NDC 64980-209-01 - HTS 3004.90.9190 HS CODE NO.: 3004 90 99 CARBAMAZEPINE EXTENDED RELEASE TABLETS 400MG,NDC 16571-682-01-HTS CODE 3004.90.9230 HS CODE NO.: 3004 90 81 CUSTOMS INVOICE NO.: 1240625758 DT.24.07.2024 1240625759 DT.24.07.2024 COMMERCIAL INVOICE NO.: 90029136 DT.24.07.2024 90029137 DT.24.07.2024 NET WEIGHT : 3,472.010 KGS HIND CYCLE ROAD, WORLI, MUMBAI 400 030, INDI TEL: 30451397/259 MARCELLA.RODRIGUEZ SAVINODELBENE.COM RISINGPHARMA.NY SAVINODELBENE.COM CMA-CGM NVOCC HOUSE BILLS CROSS REFERECNE WI MASTER BILLS NO AMC2248906 FREIGHT COLLECT -------------GENERIC DESCRIPTION-------------CARGO IS STOWED IN A REFRIGERATED CONTAINER S THE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS |
| 2024-07-30 |
SULPTHN008555NYC |
RISING PHARMA HOLDINGS INC |
6764.0 kg |
300490
|
779 CARTONS ON 40 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO204967 4500014142 2050384500014683 2049974500014324 205018 4500014502 GLIPIZIDE EXTENDED RLEASE TABLETS 2.5MG NDC: 6498027903 HTS CODE:3004909190 HS CODE 3004 90 99 MIDODRINE HYDR OCHLORIDE TABLETS USP 5MG 100 CT NDC: 6498043 401 HTS CODE: 3004909220 HS CODE NO3004 90 99CUSTOMS INVOICE NO: 1240625496 DT 18.06.2024 1240625500 DT 18.06.2024 COMMERCIAL INVOICE NO: 90028909 DT . 18.06.2024 SB NO:1761975 DT. 18.06.2024, 1761998 DT.18.06.2024 NET WT 4383.400 |
| 2024-07-30 |
SULPTHN008553NYC |
RISING PHARMA HOLDINGS INC |
6232.0 kg |
300490
|
621 CARTONS ON 35 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 205051 4500014860 205018 4500014502 CETIRIZINE HYDROCHLORIDE TABLETS 10MG 500CT NDC 1657140250 HTS 3004.90.9180 HS CODE NO.: 3004 9031 GLIPIZIDE EXTENDED RELEASE TABLETS 10MG 1 00CT NDC 6498028101 HTS CODE 3004.90.9190 HS CODE : 3004 90 99 GLIPIZIDE EXTENDED RELEASE TABLETS 5MG 100CT NDC 6498028001 HTS CODE 3004.90.9190 HS CODE : 3004 90 99 SB NO: DT. NETWT.:4462.670 KGS |
| 2024-07-30 |
SULPTHN008552NYC |
RISING PHARMA HOLDINGS INC |
5804.0 kg |
300490
|
800 CARTONS ON 35 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO: 205030 4500014698 205042 4500014679 205040 4500014684 205032 4500014677 204969 4500014144 205000 4500014327 204949 4500012841 205031 4500014704 205032 4500014677 BLUE POINT- DICLOFENAC SODIUM DELAYED-RELEASE TABLETS USP 25M G 100CT NDC 68001-279-00- HTS 3004.90.9120 HSCODE : 3004 90 69 DICLOFENAC SODIUM DELAYED- RELEASE TABLETS, USP 25MG 100CT NDC 16571-20 3-10- HTS 3004.90.9120 HS CODE : 3004 90 69 TINIDAZOLE TABLETS 500MG 12CT NDC 64980-427-12- HTS 3004.90.9110 HS CODE NO.: 3004 90 23 C ARBAMAZEPINE EXTENDED RELEASE TABLETS 100MG,00 CT NDC 16571-680-01- HTS CODE 3004.90.9230 HS CODE NO.:004 90 81 OXYBUTYNIN CHLORIDE EXTENDED- ELEASE TABLETS, USP 5MG 100CT NDC 64980-209-1 HTS 3004.90.9190 HS CODE : 3004 90 99CLOTRIMAZOLE TROCHE LOZENGE 10 MG 70CT NDC 1 657168607 HS CODE : 3004 90 99 CLOTRIMAZOLE TROCHE LOZENGE 10 MG 70CT NDC 1657168614 HS CODE : 3004 90 99 BLUE POINT- MLIZINE HYDROCHLORIDE CHEWABLE TABLETS 25 MG 100 CT NDC 680015 2900 HTS 3004.90.9280 HS CODE : 3004 90 39 CARBAMAZEPINE EXTENDED RELEASE TABLETS 200MG 100 ACT NDC 1657168101 HTS CODE 3004.90.9230 HSCODE NO.: 3004 90 81 SB NO: DT. NET WT.:4094 .120 KGS |
| 2024-07-30 |
SULPTHN008556NYC |
RISING PHARMA HOLDINGS INC |
7001.0 kg |
300490
|
875 CARTONS ON 38 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 205047 4500014727 205051 4500014860 2050424500014679 205030 4500014698 205033 45000146 78 205041 4500014685 205034 4500014680 2050384500014683 205031 4500014704 205037 45000146 82 LORATADINE TABLETS USP 10 MG 300CT NDC 165 71-0822-30 - HTS CODE 3004.90.9280 HS CODE NO.: 3004 90 39 CETIRIZINE HYDROCHLORIDE TABLETS 10MG 500CT NDC 16571-402-50 - HTS 3004.90.9180 HS CODE NO.: 3004 90 31 DICLOFENAC SODIUMDELAYED-RELEASE TABLETS, USP 50MG 1,000CT ND C 16571-202-11 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 BLUE POINT - DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, USP 50MG 60CT - NDC 6 8001-280-06 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 BLUE POINT - DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, USP 50MG 100CT - NDC 68001-280-00 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 BLUE POINT - DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, USP 50MG 1,000CT - NDC 68001-280-08 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 CLOMIPRAMINE CAPS 75MG 30CT NDC 16571 -068-503-HTS 3004.90.9235 HS CODE NO.: 3004 90 99 CLOMIPRAMINE CAPS 75MG 90CT NDC 16571-068-509-HTS 3004.90.9235 HS CODE NO.: 3004 90 99 TOLTERODINE TARTRATE TAB 2 MG 60 CT NDC 16571-127-06- HTS 3004.90.9265 HS CODE NO.: 300490 99 GLIPIZIDE EXTENDED-RELEASE TABLETS 10M G 500CT NDC 64980-281-05 - HTS CODE 3004.90.9190 HS CODE : 3004 90 99 MIDODRINE HYDROCHLOR IDE TABLETS, USP 2.5MG 100 CT NDC 64980-433-01 - HTS CODE 3004.90.9220 HS CODE NO.: 3004 90 99 BLUE POINT - MECLIZINE HYDROCHLORIDE CHEWABLE TABLETS 25 MG 1000 CT NDC 68001-529-08 - HTS 3004.90.9280 HS CODE : 3004 90 39 MECLIZINE HYDROCHLORIDE CHEWABLE TABLETS 25MG 100CT-NDC 16571-824-01-HTS 3004.90.9280 HS CODE :3004 90 39 CUSTOMS INVOICE NO.: 1240625497 D T.18.06.2024 1240625498 DT.18.06.2024 1240625502 DT.18.06.2024 COMMERCIAL INVOICE NO.: 90028910 DT.18.06.2024 SB NO: 1764178 DT.18.06.2024 1764173 DT.18.06.2024 1764180 DT.18.06.2024 NET WT.: 4997.240 KGS |
| 2024-07-14 |
OOLU230274523001 |
RISING PHARMA HOLDINGS INC |
6962.0 kg |
310510
|
GLIPIZIDE EXTENDED-RELEASE TABLETS 10MG 500CT |
| 2024-07-04 |
OOLU230256144001 |
RISING PHARMA HOLDINGS INC |
7774.0 kg |
310510
|
CIPROFLOXACIN TABLETS, GLIPIZIDE EXTENDED-RELEASE TABLETS , |
| 2024-07-04 |
OOLU230273891001 |
RISING PHARMA HOLDINGS INC |
4905.0 kg |
310510
|
CETIRIZINE HYDROCHLORIDE TABLETS 10MG 500CT,ATENOLOL TABLETS |
| 2024-06-26 |
OOLU230256143001 |
RISING PHARMA HOLDINGS INC |
6461.0 kg |
310420
|
OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS |
| 2024-06-17 |
MEDUFS287011 |
RISING PHARMA HOLDINGS INC |
6790.0 kg |
300490
|
1 X 40FT HC RF CONTAINER C ONTAINS 1405 CARTONS ON 4 0 PACKAGES (ONE THOUSAND FOUR HUNDREDFIVE CARTONS ON FORTY PACKAGES ONLY) SHIPMEN T OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 204935 (4 500013873) 204953 (4 500014 103) 204965 (4500014140) 2 05025 (4500014524) 204996 (4500014323) CETIRIZINE H YDRO CHLORIDE TABLETS 5MG 1 00CT NDC 16571-401-10 - HTS 3004.90.9180 HS CODE : 3004 90 69 DICLOFENAC SO DIUM DELAYED-RELEASE TABLE TS, USP 75MG 1,000CT NDC 1 6571-201-11 - HTS 3004.90. 9120 HS CODE : 3004 90 69 DICLOFENAC SODIUM DELAYED -RELEASE TABLETS, USP 75MG 100CT NDC 16571-201-10 - HTS 3004.90.9120 HS CODE : 300490 69 CUSTOMS INV OICE NO.: 1240625153 DT.2 9.04.2024 COMMERCIAL INVOI CE NO.: 90028623 DT.30.0 4.2024 SB NO: 9501463 DT. 29.04.2024 NET. WT. 4,685. 460 KGS THE TEMPERATURE TO BE SET AT +18 DEGREE CELC IUS IN ACCORDANCE WITHSHI PPER INSTRUCTIONS |
| 2024-06-17 |
MEDUFS287052 |
RISING PHARMA HOLDINGS INC |
7223.0 kg |
300420
|
1 X 40FT HC RF CONTAINER C ONTAINS 1209 CARTONS ON 42 PALLETS (ONE THOUSAND TWO HUNDRED NINE CARTONS O N FORTY TWO PACKAGES ONLY) SHIPMENT OF PHARMACEUT ICAL FINISHED FORMULATION AS PER ORDER NO.: 204 995 (4500014322) 205001 (4500014328) 205021 (450 0014505) 205024 (4500014 523) 205020 (4500014504) 205023 (4500014 522) 2 04994 (4500014321) 20499 2 (4500014319) 204996 (4 500014323) 204945 (45000 13877) 205025 (450001452 4) CIPROFLOXACIN TABLETS , UPS 500MG 500CT NDC 1 6571-412-50 - HTS 3004.20. 0060 HS CODE : 3004 20 1 3 TOLTERODINE TARTRATE T AB 1 MG 60 CT NDC 16571- 126-06- HTS 3004.90.9265 HS CODE NO.: 3004 90 99 TOLTERODINE TARTRATE TAB 2 MG 60 CT NDC 16571-127 -06 - HTS 3004.90.9265 HS CODE NO.: 3004 90 99 MIDODRINE HYDROCHLORIDE TAB LETS, USP 5MG 100 CT NDC 64980-434-01 - HTS CODE 3004.90.9220 HS CODE NO. : 3004 90 99 BLUE POINT - DICLOFENAC SODIUM DELAYE D-RELEASE TABLETS, USP 50M G60CT - NDC 68001-280-06 - HTS 3004.90.9120 H S CO DE : 3004 90 69 BLUE POI NT - DICLOFENACSODIUM DEL AYED-RELEASE TABLETS, USP 50MG 10 0CT - NDC 68001-280 -00 - HTS 3004.90.9120 H S CODE : 3004 90 69 BLUE POINT - DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, USP 75MG 60CT - NDC 68001- 281-06 - HTS 3004.90.9120 HS CODE : 3004 90 69 B LUE POINT - DICLOFENAC SOD IUM DELAYED-RELEASE TABLET S, USP 75MG 100CT -NDC 68 001-281-00 - HTS 3004.90.9 120 HS COD E : 3004 90 69 MECLIZINE HYDROCHLORIDE CHEWAB LE TABLETS 25MG 100 CT-NDC 16571-824-01-HTS 30 04.90.9280 HS CODE : 300 4 90 39 BLUE POINT- MEC LIZINE HYDROCHLORIDE CHEWA BLE TABLETS 12.5 MG 100 C T NDC 68001-528-00 - HTS 3 004 .90.9280 HS CODE : 30 04 90 39 CARBAMAZEPINE E XTENDED RELEASE TABLETS 10 0MG,100 CT NDC 16571-680 -01-HTS CODE 3004.90.9230 HS CODE NO.: 3004 90 81 DICLOFENAC SODIUM DELAYE D-RELE ASE TABLETS, USP 50M G 60CT NDC 16571-202-06 - HTS 3004.90.9120 HS C ODE : 3004 90 69 DICLOFE NAC SODIUM DELAYED-RELEASE TABLETS, USP 75MG 60CT NDC 16571-201-06 - HTS 3 004.90.9120HS CODE : 30 04 90 69 DICLOFENAC SODI UM DEL AYED-RELEASE TABLETS , USP 50MG 1,000CT NDC 16571-202-11 - HTS 3004.90. 9120 HS CODE : 30 04 90 6 9 CUSTOMS INVOICE NO.: 1240625148 DT. 29.04.2024 1 240625154 DT.29.04.2024 12 40625156 DT.29.04.2024 CO MMERCIAL INVOICE NO.: 900 28622 DT.30.04.2024 SB NO : 9501477 DT.29.04.2024 95 01481 DT.29.04.2024 950148 7 DT.29.04.2024 NET. WT. 5,135.350 KGS === MARCEL LA.RODRIGUEZ=SAVINODELBENE .COM RISINGPHARMA.NY=SAVIN ODELBENE.COM CONTACT NO.: +1-718-906-2732 THE TEMPE RATURE TO BE SET AT +18 DE GREE CELCIUS IN ACCORDANCE WITH SHIPPER INSTRUCTIONS |
| 2024-06-04 |
MEDUFS133025 |
RISING PHARMA HOLDINGS INC |
7981.0 kg |
300490
|
1X40 FT HC RF CONTAINER C ONTAINS 1080 CAR TONS ON 38 PACKAGES (ONE THOUSA ND EIGHTY CARTONS ON THIRT Y EIGHT PACKAGES ONLY) SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION A S PER ORDER NO.: 20499 6 (4500014323) 204935 (4 500013873) 204996 (45000 14323) DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, USP 75MG 60CT NDC 1657 1-201-06 - HTS 30 04.90.912 0 HS CODE : 3004 90 69 CETIRIZINE HYDROCHLORIDE TABLETS 10MG 500CT NDC 1657 1-402-50 - HTS 3004.90 .9180 HS CODE NO.: 3 004 90 31 NET WEIGHT : 5,817 .470 KGS GR OSS WEIGHT: 7,981.220 KGS CUSTOMS IN VOICE N O.: 1240625062 DT : 22.04.2024 COMMERCIAL INVOICE NO.: 90028550 D T: 22.04.2024 S .BILL NO : 9311492 DT.22.04.2024 FREIGTHT P REPAID TEMPE RATURE : +18 DEGREE CELS I US VENT. : CLOSED, HU MIDITY. : NA = WORLI, MUMBAI 400030, INDIA. TEL: 30451397/2 59 == MA IL I D MARCELLA.RODRIGUEZ= SAVINO DELBENE.COM RISINGPH ARMA.NY=SAVINODELBENE.COM CONTACT NO.: +1-718-906-27 32 THE TEMPERA TURE TO BE SET AT +18 DEGREE CELCIUS IN ACCOR DANCE WITH SHIPPE R INSTRUCTIONS |
| 2024-06-04 |
HLCUBO1ODBGRC0AA |
RISING PHARMA HOLDINGS INC |
7602.0 kg |
300490
|
SHIPMENT OF PHARMACEUTICAL 1 X 40FT HC RF CONTAINER CONTAINS TOTAL 39 PACKAGES 1273 CARTONS ON 39 PACKAGES (ONE THOUSAND TWO HUNDRED SEVENTY THREE CARTONS ON THIRTY NINE PACKAGES ONLY) SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO. 204965 (4500014140) 205025 (4500014524) CETIRIZINE HYDROCHLORIDE TABLETS 10MG 500CT NDC 16571-402-50 - HTS 3004.90.9180 HS CODE 3004 90 69 DICLOFENAC SODIUM DELAYED -RELEASE TABLETS, USP 75MG 60CT NDC 16571-201-06 - HTS 3004.90.9120 HS CODE 3004 90 69 DICLOFENAC SODIUM DELAYED- RELEASE TABLETS, USP 75MG 100CT NDC 16571-201-10 - HTS 3004.90.9120 HS CODE 3004 90 69 CUSTOMS INVOICE NO. 1240625217 DT.30.04.2024 COMMERCIAL INVOICE NO. 90028650 DT.30.04.2024 SB NO 9534234 DT.30.04.2024 NET WEIGHT 5,630.300 KGS FREIGHT PREPAID |
| 2024-06-04 |
HLCUBO1ODBGRA8AA |
RISING PHARMA HOLDINGS INC |
7519.0 kg |
300490
|
LITHIUM CARBONATE EXTENDED-RELEASE 1 X 40FT HC RF CONTAINER CONTAINS TOTAL 40 PACKAGES 835 CARTONS ON 40 PACKAGES (EIGHT HUNDRED THIRTY FIVE CARTONS ON FORTY PACKAGES ONLY) SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO. 205019 (4500014503) 204955 (4500014105) 204967 (4500014142) 204948 (4500013972) 204997 (4500014324) 204967 (4500014142) LITHIUM CARBONATE EXTENDED -RELEASE TABLETS, USP 300MG 500CT NDC 64980-205-05 - HTS 3004.90.9135 HS CODE 3004 90 99 GLIPIZIDE EXTENDED-RELEASE TABLETS 5MG 100CT NDC 64980-280-01 - HTS CODE 3004.90.9190 HS CODE 3004 90 99 OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS, USP 10MG 100CT NDC 64980-210-01 - HTS 3004.90.9190 HS CODE 3004 90 99 GLIPIZIDE EXTENDED-RELEASE TABLETS 5MG 500CT NDC 64980-280-05 - HTS CODE 3004.90.9190 HS CODE 3004 90 99 CUSTOMS INVOICE NO. 1240625223 DT.30.04.2024 1240625226 DT.30.04.2024 COMMERCIAL INVOICE NO. 90028651 DT.30.04.2024 90028652 DT.30.04.2024 SB NO 9543477 DT.01.05.2024 9543488 DT.01.05.2024 NET WEIGHT 5,339.760 KGS FREIGHT PREPAID |
| 2024-06-04 |
OOLU230234357001 |
RISING PHARMA HOLDINGS INC |
3602.0 kg |
292119
|
CETIRIZINE HYDROCHLORIDE,OXYBUTYNIN CHLORIDE, |
| 2024-06-04 |
OOLU230234358001 |
RISING PHARMA HOLDINGS INC |
8971.0 kg |
310510
|
GLIPIZIDE EXTENDED-RELEASE TABLETS 5MG 1,000CT |
| 2024-06-02 |
OOLU230221626001 |
RISING PHARMA HOLDINGS INC |
7992.0 kg |
310510
|
CETIRIZINE HYDROCHLORIDE TABLETS 10MG 500CT |
| 2024-06-02 |
OOLU230221631001 |
RISING PHARMA HOLDINGS INC |
7636.0 kg |
310420
|
OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS |
| 2024-05-21 |
OOLU230219860001 |
RISING PHARMA HOLDINGS INC |
6983.0 kg |
310510
|
LORATADINE TABLETS USP 10 MG |
| 2024-05-18 |
MEDUJ7316121 |
RISING PHARMA HOLDINGS INC |
8153.0 kg |
300490
|
1 X 40FT HC RF CONTAINER C ONTAINS TOTAL 39 PACKAGE S 1260 CARTONS ON 39 PAC KAGES (ONE THOUSAND TWO HUNDRED SIXTY CARTONS ON THIRTY NINE PACKAGES ONLY) SHIPMENT OF PHARMACEUT ICAL FINISHED FORMULATION AS PER ORDER NO.: 2049 46 (4500013805) 204955 ( 4500014 105) 204967 (4500 014142) 204948 (4500013 9 72) 204962 (4500014128) VENLAFAXINE ER TA BS 225 MG 30CT NDC 64980-581-03 - HTS 3004. 90.9235 HS CO DE NO.: 3004 90 99 GLIPI ZI DE EXTENDED-RELEASE TABL ETS 10MG 500CT ND C 6498 0-281-05 - HTS CODE 3004.9 0.9190 HS CODE NO.: 3004 90 99 GLIPIZIDE EXTENDE D-R ELEASE TABLETS 10MG 1,0 00CT NDC 64980-28 1-10 - HTS CODE 3004.90.9190 HS CODE NO.: 300 4 90 99 OXYBUTYNIN CHLORIDE EXTEND ED-RELEASETABLETS, USP 5M G 100CT NDC 64980-209-01 - HTS 3004.90.9190 HS CO DE NO.: 3004 90 99 OXYBU TYNIN CHLORIDE EXTENDED-RE LEASE TABLE TS, USP 5MG 500 CT NDC 64980-209-05 - HTS 30 04.90.9190 HS CODE NO .: 3004 90 99 DICLO FENAC SODIUM DELAYED-RELEASE TA BLETS, USP 75MG 100CT NDC 16571-201-10 - HTS 3004.9 0.912 0 HS CODE NO.: 3004 90 69 CUSTOMS INVOICE N O.: 1230627359 DT.27.0 3.2024 123062 7385 DT.28. 03.2024 1230627391 DT.28 .03.20 24 1230627392 DT.2 8.03.2024 COMMERCI AL INVOICE NO.: 90028471 DT.28.03.2024 90028472 DT.28.03.2024 SB NO: 8680377 DT.27 .03.2024 87 39352 DT.29.03.2024 874 0987 DT.29.03.2024 87394 12 DT.29.03.2024 THE TEM PERATURE TO BE SET AT 18 D EGREE CELCIUS IN ACCORDANC E WITH SHIPPER INSTRUCTION S |
| 2024-05-12 |
MEDUJ7232583 |
RISING PHARMA HOLDINGS INC |
7109.0 kg |
300490
|
1 X 40FT HC RF CONTAINER C ONTAINS 819 CARTONS ON 3 7 PACKAGES (EIGHT HUNDRE D NINETEEN CARTONS ON THIR TY SEVEN PACKAGES ONLY) S HIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PE R ORDER NO.: 204962 (45000 14128) 204952 (450001410 2) 204964 (4500014139) 204948 (4500013972) 204 961 (4500014127) 204944 (45000138 78) 204955 (450 0014105) 204967 (4500014 142)DICLOFENAC SODIUM D ELAYED-RELEASE TABLETS, US P 75MG 100CT NDC 16571-20 1-10 - HTS 3004.90.9120 HS CODE NO.: 3004 90 69 CARBAMAZEPINEEXTENDED REL EASE TABLETS 200MG, 100CT NDC 1 6571-681-01-HTS CODE 3004.90.9230 HS CODE NO.: 3004 90 81 OXYBUTYNIN CHLORIDE EXTENDED-RE LEASE TABLETS, USP 15MG 100CT N DC 64980-211- 01 - HTS 3004 .90.9190 HS CODE NO.: 30 04 90 99 OXYBUTYNIN CHLO RIDE EXTENDED-RELEASE TABLETS, USP 5MG 100CT NDC 6 4980-209-01 - HTS 3 004.90. 9190 HS CODE NO.: 3004 9 0 99 BLUE POINT - DICLOF ENAC SODIUM DELAYED-RELEAS E TABLETS, USP 75MG 500CT - NDC 68001-281-03 - HTS3 004.90.9120 HS CODE NO.: 3004 90 69 GLIPIZ IDE EX TENDED-RELEASE TABLETS 5MG 100CT NDC 6 4980-280-01 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 GLIPIZIDE EXTENDED-RELEASE TABLETS 5MG 500CT NDC 6 4980-280-05 - HTS CODE 300 4.90.9190 HS CODE NO.: 3 004 90 99 CUSTOMSINVOIC E NO.: 1230627334 DT.26.03 .2024 1230 627339 DT.26.03. 2024 1230627335 DT.26.03.2 024 COMMERCIAL INVOICE NO. : 90028407 & 90028408 DT.2 6.03.2024 SB NO: 8646295 D T.26.03.20 24 8646305 DT.26 .03.2024 8646290 DT.26.03. 2024 NET. WT. 5,233.350 K GS TEMP : PLUS 18 DC# # MARCELLA.RODRIGUEZ=SAV INODELBENE.COM RI SINGPHA RMA.NY=SAVINODELBENE.COM CONTACT NO.:+1-718-906-2 732 THE TEMPERATURE TO BE SET A T +18 DEGREE CELCIU IN ACCORDANCE WITH SHIPPER INSTRUCTIONS |
| 2024-05-12 |
MEDUJ7269049 |
RISING PHARMA HOLDINGS INC |
6512.0 kg |
300490
|
768 CARTONS ON 41 PACKAGES (SEVEN HUNDRED SIXTY EI GHT CARTONS ON FORTY ONE P ACKAGES ONLY) SHIPMENT O F PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER N O.: 204946 (4500013805) 204948 (4500013972) 204967 (4500014142) VENLAFAXINE ER TABS 150 MG 30CT NDC 64980-580-03- HTS 3004.90. 9235 HS CODE NO.: 3004 9 0 99 VE NLAFAXINE ER TABS 150 MG 90CT NDC 64980-5 80-09- HTS 3004.90.9235 HS CODE NO.: 3004 90 99 VENLAFAXINE ER TABS 225 MG 30CT NDC 64980-581-03- HTS 3004.90.9235 HS CODE NO.: 3004 90 99OXYBUTY NIN CHLORIDE EXTENDED-RELE ASE TABLE TS, USP 5MG 100CT NDC 64980-209-01 - HTS 3 004.90.9190 HS CODE NO.: 3004 90 99 GLIPIZIDE EX TENDED-RELEASE TABLETS 10M G 500CT NDC 6498 0-281-05 - HTS CODE 3004.90.9190 HS CODE NO.:3004 90 99 GLIPIZIDE EXTENDED-RELEAS E TABLE TS 5MG 500CT NDC 64980-280-05 - HTS CODE 30 04.90.9190 HS CODE NO.: 3004 90 99 CUSTOMS INVOI CE NO. 1230627345 DT.26.0 3.2024 1230627347 DT.26.03 .2024 1230627354 DT.26.03. 2024 COMMERCIAL INVOICE NO . 90028412 & 90028413 DT .26.03.2024 SB NO. 864721 4 DT.27.03.2024 864 7112 DT .26.03.2024 8647118 DT.26. 03.2024 NET. WT. 4,596.620 KGS TEMP : PLUS 18 DC THE TEMPERATURE TO BE SE T AT +18 DEGREE CELCIUS INACCORDANCE WITH SHIPPER I NSTRUCTIONS ## MA RCELLA .RODRIGUEZ=SAVINODELBENE.C OM RISINGPHARMA.NY=SAVIN ODELBENE.COM CONTACT NO. : +1-718-906-2732 |
| 2024-05-12 |
MEDUJ7228037 |
RISING PHARMA HOLDINGS INC |
7875.0 kg |
300490
|
1 X 40FT HC RF CONTAINER C ONTAINS 1065 CAR TONS ON 40 PACKAGES (ONE THOUSAN D SIXTY FI VE CARTONS ON FORTY PACKAGES ONLY) SHI PM ENT OF PHARMACEUTICAL FINISHED FORMULATION ASPE R ORDER NO.: 204962 (450 0014128) 204 922 (4500013 678) 204944 (4500013878) 20495 5 (4500014105) D ICLOFENAC SODIUM DELAYED-R ELEASE TABLETS, USP 50MG 6 0CT NDC 16571-2 02-06 - H TS 3004.90.9120 HS CODE NO.: 3004 90 69 DICLOFEN AC SODIUM DELAYED-RELEASE T ABLETS, USP 50MG 100CT N DC 16571-202-10 - H TS 3004 .90.9120 HS CODE NO.: 30 04 90 69 DICLOFENAC SODI UM DELAYED-RELEASE TABLETS , USP 50MG 1,000CT NDC 16 571-202-11 - HTS 30 04.90.9 120 HS CODE NO.: 3004 90 69 DICLO FENAC SODIUM DE LAYED-RELEASE TABLETS, USP 75MG 60CT NDC 16571-201 -06 - HTS 3004.90.912 0 H S CODE NO.: 3004 90 69 G LIPIZIDE EXT ENDED-RELEASE TABLETS 5MG 500CT NDC 64 980- 280-05 - HTS CODE 3004 .90.9190 HS CODE NO. : 30 04 90 99 CUSTOMS INVOICE NO.: 123062 7316 DT.23.0 3.2024 1230627325 DT.23. 03.20 24 COMMERCIAL INVOI CE NO.: 90028396 DT.23. 03. 2024 NET. WT. 5,661.790 KGS TEMP : PL US 18 DC == INDIA. TEL: 30451397 /259 ## MARCELLA RODRI GUEZ MARCELLA.RODRIGUEZ= S AVINODELBENE.COM RISING PHARMA.NY=SAVINODEL BENE.CO M CONTACT NO.: +1-718-90 6-2732 T HE TEMPERATURE T O BE SET AT +18 DEGREE CEL CIUS IN ACCORDANCE WITH SH IPPER INSTRUCTIONS |
| 2024-05-08 |
HLCUBO1OCBHIK8AA |
RISING PHARMA HOLDINGS INC |
6035.0 kg |
300490
|
CETIRIZINE HYDROCHLORIDE TABLETS 1 X 40FT HC RF CONTAINER CONTAINS TOTAL 38 PACKAGES 438 CARTONS ON 38 PACKAGES (FOUR HUNDRED THIRTY EIGHT CARTONS ON THIRTY EIGHT PACKAGES ONLY) SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO. 204953 (4500014103) 204935 (4500013873) CETIRIZINE HYDROCHLORIDE TABLETS 10MG 500CT NDC 16571-402-50 - HTS 3004.90.9180 HS CODE NO. 3004 90 31 CETIRIZINE HYDROCHLORIDE TABLETS 5MG 100CT NDC 16571-401-10 - HTS 3004.90.9180 HS CODE NO. 3004 90 31 CUSTOMS INVOICE NO. 1230627364 DT.27.03.2024 COMMERCIAL INVOICE NO. 90028432 DT.27.03.2024 SB NO 8675129 DT.27.03.2024 NET WEIGHT 5023.060 KGS FREIGHT PREPAID |
| 2024-04-23 |
SULPTHN008129NYC |
RISING PHARMA HOLDINGS INC |
6203.0 kg |
300490
|
875 CARTONS ON 35 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS PER ORDER NO.: 204916 4500013656, 204948 4500013972 204952 4500014102, 204944 4500013878 204958 4500014109, 204959 4500014110 204955 4500014105, 204951 4500014101 204956 4500014106, 204957 4500014107 204968 4500014143 OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS, USP 10MG 100CT NDC 64980-210-01 - HTS 3004.90.9190 HS CODE NO.: 3004 90 99 OXYBUTYNIN CHLORIDE EXTENDED-RELE ASE TABLETS, USP 15MG 100CT NDC 64980-211-01 - HTS 3004.90.9190 HS CODE NO.: 3004 90 99 OXYBUTYNIN CHLORIDE EXTENDED-RELEASE TABLETS, USP 10MG 500CT NDC 64980-201-05 - HTS 3004.90.9190 HS CODE NO.: 3004 90 99 CARBAMAZEPINE EX TENDED RELEASE TABLETS 100MG,100 CT NDC 16571-680-01- HTS CODE 3004.90.9230 HS CODE NO.: 3004 90 81 GLIPIZIDE EXTENDED- RELEASE TABLETS10MG 1,000CT NDC 64980-281-10 - HTS CODE 300 4.90.9190 HS CODE NO.: 3004 90 99 TINIDAZOLE TABLETS 500MG 12CT NDC 64980-427-12 - HTS 3004.90.9110 HS CODE NO.: 3004 90 23 TOLTERODINETARTRATE TAB 2 MG 60 CT NDC 16571-127-06- HT S 3004.90.9265 HS CODE NO.: 3004 90 99 GLIPIZIDE EXTENDED- RELEASE TABLETS 10MG 500CT NDC 64980-281-05 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 BLUE POINT - MECLIZINE HYDROCHLORIDE CHEWABLE TABLETS 25 MG 1000 CT NDC 68001-529-08 - HTS 3004.90.9280 HS CODE : 3004 90 39 LORATADINE TABLETS USP 10 MG 30CT NDC 16571-822-03 - HTS CODE 3004.90.9280 HS CODE N O.: 3004 90 39 MECLIZINE HYDROCHLORIDE CHEWABLE TABLETS 25MG 100CT NDC 16571-824-01- HTS 3004.90.9280 HS CODE : 3004 90 39 LORATADINE TABLETS USP 10 MG 300CT NDC 16571-822-30 - HTSCODE 3004.90.9280 HS CODE NO.: 3004 90 39 CU STOMS INVOICE NO.: 1230627265 DT.21.03.2024 1230627266 DT.21.03.2024 1230627268 DT.21.03.2024 1230627270 DT.21.03.2024 NET WT: 4282.040 KGS |
| 2024-04-23 |
SULPTHN008125NYC |
RISING PHARMA HOLDINGS INC |
7641.0 kg |
300490
|
1065 CARTONS ON 41 PACKAGES SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATION AS 204919 4500013667 204935 4500013873 204953 4500014103 204965 4500014140 204962 4500014128 CETIRIZINE HYDROCHLORIDE TABLETS 5MG 100CT NDC 16571-401-10- HTS 3004.90.9180 HS CODE NO.:30049031 CETIRIZINE HYDROCHLORIDE TABLETS 10MG 100CT NDC 16571-402-10- HTS 3004.90.9180 HS CODE NO.:3 0049031 CETIRIZINE HYDROCHLORIDE TABLETS 10MG500CT NDC 16571-402-50- HTS 3004.90.9180 HS CODE NO.:30049031 DICLOFENAC SODIUM DELAYED-RELEASE TABLETS, USP 75MG 1,000CT NDC 16571-201-11- HTS 3004.90.9120 HS CODE NO.:30049069 CUSTOMS INVOICE NO.: 1230627272 DT.21.03.2024 COMMERCIAL INVOICE NO.: 90028340 DT.21.03.202 4 NET WT: 5520.800 KGS |
| 2024-04-16 |
MEDUE7779550 |
PANAMEDICAL DE COSTA RICA S A |
10899.0 kg |
847439
|
IOHEXOL 64.7 PCT(IOHEXOL INJECTION USP300MG I/ML - 1X40FT HC CONTAINER CONTAI NING 551 C ARTONS (23 PAL LETS) DESCRIPTION OF GOODS AND/OR SERVICES + 55,000 IO HEXOL 64.7 PCT(IO HEXOL INJ ECTION USP300MG I/ML ACCO RDING TO PURCHASE ORDER P- 06-22.IIPER.(III DEL.) S HIPPING TERMS: CIF ANY POR T OF COSTA RICA, INCOTERMS 2020. CUSTOM INVOICE NO : 1230 627140 DT.29.02.2 024 COMMERCIAL INVOICE N O: 90028225 DT.29.02.20 24 SB.NO: 795624 6 DT.29. 02.2024 IRREVOCABLE DOCU MENTARY CREDIT NUMBER: LC-682/23 DATE OF ISSUE: 2 40227 REF: LC-682/23. FREIGHT PREPAID DOOR D ELIVERY ADDRESS: PANAMEDIC AL DE COSTA RICA, S.A. (O FIPLAZA DEL ESTE, EDIFICIO C, III PI SO, SAN JOSE, CO STA RICA, |
| 2024-04-08 |
MIPJMTRMUM240079 |
PHARMACEUTICAL TECHNOLOGY |
13460.0 kg |
300510
|
SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATI30049069 . . |
| 2024-04-04 |
MEDUE7622214 |
RISING PHARMA HOLDINGS INC |
7769.0 kg |
300490
|
1 X 40FT HC RF CONTAINER C ONTAINS 1083 CAR TONS ON 41 PACKAGES (ONE THOUSAN D EIGHTY T HREE CARTONS ON FORTY ONE PACKAGES ONLY) SHIPMENT OF PHARMACEUTICA L FINISHED FORMULATION AS PER ORDER NO.: 204905 (4 500013456) 20 4936 (45000 13874) 204944 (450001387 8) 2 04942 (4500013880) CETIRIZINE HYDROCHLORIDE T ABLETS 10MG 100CT NDC 1 6571-402-10 - HTS 3 004.90. 9180 HS CODE NO.: 3004 9 0 31 CIP ROFLOXACIN TABLE TS, UPS 500MG 500CT NDC 16 571-412-50 - HTS 3004.20 .0060 HS CODE NO.: 3004 20 13 GLIPIZIDE EXTENDED -RELEASE TAB LETS 5MG 100CT NDC 64980-280-01 - HTS CODE 3004.90.9190 HS COD E NO.: 3004 90 99 LORAT A DINE TABLETS USP 10 MG 100 CT NDC 16571-0 822-01 - H TS CODE 3004.90.9280 HS CODE NO. : 3004 90 39 CUS TOMS INVOICE NO.: 123062 7029 DT.19.02.2024 12306 27030 DT.19.02.20 24 COMM ERCIAL INVOICE NO.: 90028 122 DT.1 9.02.2024 NET. W T. 5,419.860 KGS TEMP : +18 DGREE. THE TEMPERAT URE TO BE SET AT + 18 DEGRE E CELCIUS IN ACCORDANCE WI TH SHIPPER INSTRUCTIONS == MARCELLA.RODRIGUEZ=SAVI NOD ELBENE.COM RISINGPHAR MA.NY=SAVINODELBENE.C OM CONTACT NO.: +1-718-906-27 32 |
| 2024-04-02 |
OOLU230175843001 |
RISING PHARMA HOLDINGS INC |
6513.0 kg |
291813
|
PHARMACEUTICAL TOLTERODINE TARTRATE TAB 2 MG 60 CT |
| 2024-04-02 |
CMDUAMC2179987 |
RISING PHARMA HOLDINGS INC |
6683.0 kg |
300490
|
------------ TTNU8668680 DESCRIPTION---------1 X 40FT HC RF CONTAINER CONTAINS TOTAL 41 PACKAGES 771 CARTONS ON 41 PACKAGES (SEVEN HUNDRED SEVENTY-ONE CARTONS ON FORTY-OPACKAGES ONLY) SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATI PER ORDER NO.: 204946 (4500013805) 204944 (4500013878) VENLAFAXINE ER TABS 37.5 MG 30CT NDC 64980-578-03- HTS 3004.90.9235 HS CODE NO.: 3004 90 99 VENLAFAXINE ER TABS 37.5 MG 90CT NDC 64980-578-09- HTS 3004.90.9235 HS CODE NO.: 3004 90 99 GLIPIZIDE EXTENDED-RELEASE TABLETS 10MG 100CTNDC 64980-281-01 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 GLIPIZIDE EXTENDED-RELEASE TABLETS 2.5MG 30CTNDC 64980-279-03 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 NET WEIGHT :4,386.980 KGS CMA-CGM NVOCC HOUSE BILLS CROSS REFERECNE WITMASTER BILLS NO.AMC2174573 FREIGHT COLLECT -------------GENERIC DESCRIPTION-------------CARGO IS STOWED IN A REFRIGERATED CONTAINER STHE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS |
| 2024-04-02 |
CMDUAMC2179564 |
RISING PHARMA HOLDINGS INC |
7270.0 kg |
300490
|
------------ AMCU9333026 DESCRIPTION---------1 X 40FT HC RF CONTAINER CONTAINS TOTAL 40 PACKAGES 855 CARTONS ON 40 PACKAGES (EIGHT HUNDRED FIFTY FIVE CARTONS ON FORTY PACKAGES ONLY) SHIPMENT OF PHARMACEUTICAL FINISHED FORMULATI PER ORDER NO.: 204944 (4500013878) 204963 (4500014138) 204934 (4500013872) GLIPIZIDE EXTENDED-RELEASE TABLETS 2.5MG 30CTNDC 64980-279-03 - HTS CODE 3004.90.9190 HS CODE NO.: 3004 90 99 ATENOLOL TABLETS, USP 100MG 1,000CT NDC 64980-439-10 - HTS 3004.90.9120 HS CODE NO.: 3004 90 74 ATENOLOL TABLETS, USP 25MG 1,000CT NDC 64980-437-10 - HTS 3004.90.9120 HS CODE NO.: 3004 90 74 CUSTOMS INVOICE NO.: 1230627102 DT.28.02.2024 1230627103 DT.28.02.2024 COMMERCIAL INVOICE NO.: 90028190 DT.28.02.202SB NO: 7899896 /7897980 DT.28.02.2024 NET WT : 5,775.310 KGS FREIGHT COLLECT CMA-CGM NVOCC HOUSE BILLS CROSS REFERECNE WITMASTER BILLS NO.AMC2174610 -------------GENERIC DESCRIPTION-------------CARGO IS STOWED IN A REFRIGERATED CONTAINER S THE SHIPPER S REQUESTED CARRYING TEMPERATURE DEGREES CELSIUS |